Popular
Andrew Wilner, MD, FACP, FAAN
Dejan Jakimovski, MD, PhD
Andrew Wilner, MD, FACP, FAAN
Victoria Leavitt, PhD
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Ahmed Zayed Obeidat, MD, PhD
Lauren Beranek, BS
Ashley Baker, MSN, PMHNP
Stanley N. Caroff, MD
Nancy Chiaravalloti, PhD
Ashley Baker, MSN, PMHNP
Anna Shah, MD
Heidi M. Munger Clary, MD, MPH
Jay Salpekar, MD, FANPA
Yinan Zhang, MD
W. Brian Gibler, MD, FACEP, FACC, FAHA
Natalie Kreitzer, MD, MS
Adrian R. Parry-Jones, FRCP, PhD
Rhonda Cadena, MD, FNCS, FCCM
J. William Lindsey
Andrew Wilner, MD, FACP, FAAN
George Bloom, PhD
Richard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
- MinuteCE®
What Types of Changes, If Any, Should We Expect with Amyloid-Targeting Therapy?
1.25 program creditsRichard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP